Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Page 82 - Sohini Das
Bharat Biotech to conduct additional clinical trials for USFDA nod
Timelines will be delayed; firm has received EUSs from 14 other countries
 "Bharat Biotech to conduct additional clinical trials for USFDA nod")
Hospitals grapple with post-Covid admissions, plan to add dedicated ICUs
While post-Covid patients are contributing to the footfall, there is also a pick-up in non-Covid treatment.
 "Hospitals grapple with post-Covid admissions, plan to add dedicated ICUs")
Pfizer's Covid-19 vaccine may cost less than $10 a dose in India
Govt likely to give partial indemnity to company
 "Pfizer's Covid-19 vaccine may cost less than $10 a dose in India")
Covaxin Phase-3 efficacy analysis to be made public by July: Bharat Biotech
The company is also doing phase-4 trials for real world effectiveness of the jab
Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout
Rockwell Industries has got orders for 750 Covid19 vaccine freezers from hospitals and institutions.
 "Hyderabad's Rockwell collaborates with Dr Reddy's Lab for Sputnik V rollout")
Covid-19 vaccination: Govt books 440 million doses with 30% advance
250 mn Covishield and 190 mn Covaxin doses meant for Aug-Dec period
 "Covid-19 vaccination: Govt books 440 million doses with 30% advance")
Study on Covishield, Covaxin antibody response is limited: Bharat Biotech
Raches Ella, project lead, Covid-19 vaccines at the firm says he is surprised that media and researchers are drawing conclusions based on non-peer reviewed work
 "Study on Covishield, Covaxin antibody response is limited: Bharat Biotech")
Hope to launch diabetic NCE by next financial year: Torrent Pharma's Mehta
We would also look into distribution opportunities to bring some of these products into the market, said Mehta
 "Hope to launch diabetic NCE by next financial year: Torrent Pharma's Mehta")
Bharat Biotech, Ocugen extend agreement to market Covaxin in Canada
Phase 3 analysis data to be submitted to WHO soon for EUL
 "Bharat Biotech, Ocugen extend agreement to market Covaxin in Canada")
Covid-19 pandemic: Serum Institute seeks indemnity for jab again
In talks with RDIF to manufacture Sputnik V in India
 "Covid-19 pandemic: Serum Institute seeks indemnity for jab again")
Decoded: Who can get antibody cocktail for Covid-19 and how it works
Used to treat only mild to moderate disease in high-risk Covid-19 patients, doctors feel the treatment can bolster the fight against severe disease
 "Decoded: Who can get antibody cocktail for Covid-19 and how it works")
Biological E ties up with Canadian firm Providence for mRNA Covid vaccine
The vaccine, named PTX-COVID19-B, is under development in Canada; the deal assumes significance as this gives India access to the mRNA tech
 "Biological E ties up with Canadian firm Providence for mRNA Covid vaccine")
Major states may finish Covid-19 vaccination by July 2022: Report
At the current pace, UP and Maharashtra would take 15 and 17 months respectively to cover their universal population
 "Major states may finish Covid-19 vaccination by July 2022: Report")
Wockhardt plans tie-ups for next-gen Covid-19 vax, aims to make 2 bn doses
Company aims to make 2 billion doses of vaccines in 1 to 2 years
 "Wockhardt plans tie-ups for next-gen Covid-19 vax, aims to make 2 bn doses")
For a Covid-19 vaccine, journey from lab to jab can take up to 4 months
Manufacturing alone takes 40-120 days
 "For a Covid-19 vaccine, journey from lab to jab can take up to 4 months")
We have sole selling rights, beware of fake agents of Sputnik-V: Dr Reddy's
Hyderabad-based pharma major says it isn't supplying Russia jab to residential societies
 "We have sole selling rights, beware of fake agents of Sputnik-V: Dr Reddy's")
GSK says it aims to bring FDA-approved antibody therapy to India for Covid
Treatment with Sotrovimab resulted in an 85 per cent reduction in the risk of hospitalization, says company.
 "GSK says it aims to bring FDA-approved antibody therapy to India for Covid")
Decoded: Why are black, white and yellow fungal infections on the rise now?
What are these infections, why are their cases rising and how does one protect against them?
 "Decoded: Why are black, white and yellow fungal infections on the rise now?")
Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show
Low base supported overall performance; consolidated sales from operations came in at Rs 8,431 crore, up 4.4% YoY
 "Sun Pharma Q4 net more than doubles to Rs 894 cr on better operational show")
India starts preparation to make Covid-19 care safe for children
Treatment protocols, wards with space for parents, and specially trained staff are some measures